Biopharma execs address the challenges of a post-pandemic workplace
Bristol Myers pays $200M upfront plus $1.36B in biobucks for Agenus' preclinical TIGIT asset
Novo Nordisk nets Ph2 win for former Corvidia kidney program
JNJ aims to create community for PAH patients and their doctors with new Uptravi campaign
*please scroll down for all the latest news*
